Beibei Sun
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 4
- Cancer-related Molecular Pathways 4
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 3
- Co-authors
- Feng Yao (19 shared papers)Yueling Liao (12 shared papers)Jiong Deng (12 shared papers)Hongyong Song (11 shared papers)Wenzheng Guo (10 shared papers)Haitang Yang (8 shared papers)Gérard Doussinault (1 shared paper)Josette Masle (1 shared paper)
- Journals
- Oncotarget (3 papers)Cancer Letters (2 papers)Cell Discovery (2 papers)Translational Lung Cancer Research (2 papers)EBioMedicine (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Beibei Sun
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 243
- Oncology 289
- Pulmonary and Respiratory Medicine 267
- Animal Science and Zoology 88
- Immunology 162
Countries citing papers authored by Beibei Sun
This map shows the geographic impact of Beibei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Sun more than expected).
Fields of papers citing papers by Beibei Sun
This network shows the impact of papers produced by Beibei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Sun. The network helps show where Beibei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Beibei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 100 | |
| 2 | 2018 | 80 | |
| 3 | 2019 | 78 | |
| 4 | 2021 | 77 | |
| 5 | 2014 | 76 | |
| 6 | 2022 | 65 | |
| 7 | 1989 | 64 | |
| 8 | 2018 | 60 | |
| 9 | 2020 | 58 | |
| 10 | 2019 | 55 | |
| 11 | 2009 | 45 | |
| 12 | 2010 | 41 | |
| 13 | 2015 | 39 | |
| 14 | Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features. | 2019 | 33 |
| 15 | 2016 | 31 | |
| 16 | 2021 | 31 | |
| 17 | 2024 | 29 | |
| 18 | 2021 | 29 | |
| 19 | Stabilization of PTGES by deubiquitinase USP9X promotes metastatic features of lung cancer via PGE2 signaling. | 2019 | 28 |
| 20 | 2023 | 27 |
About Beibei Sun
Beibei Sun is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Research Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (243 citations), Oncology (289 citations), Pulmonary and Respiratory Medicine (267 citations), Animal Science and Zoology (88 citations) and Immunology (162 citations). Beibei Sun has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Feng Yao, Yueling Liao, Jiong Deng, Hongyong Song, Wenzheng Guo, Haitang Yang, Gérard Doussinault, Josette Masle, Tong Wang and Kaimi Li. Their work appears in journals such as Oncotarget, Cancer Letters, Cell Discovery, Translational Lung Cancer Research and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.